University of Arkansas For Medical Services
Welcome,         Profile    Billing    Logout  
 2 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Courtney, Sherry
NCT02261883 / 2023-001028-40: Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn

Terminated
2
42
US
IV Remodulin, Treprostinil, Placebo
United Therapeutics, United Therapeutics Corp
Persistent Pulmonary Hypertension of the Newborn
09/22
05/23
PIVOTAL, NCT05547165: Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants

Recruiting
N/A
240
US
Percutaneous Patent Ductus Arteriosus Closure (PPC), Responsive Management Intervention, Echocardiogram, cardiac
Nationwide Children's Hospital, National Institutes of Health (NIH), Abbott, University of Pittsburgh, University of Bristol, Dartmouth College, University of Iowa, Emory University, Cedars-Sinai Medical Center, Children's Hospital Los Angeles, National Heart, Lung, and Blood Institute (NHLBI)
Ductus Arteriosus, Patent
02/26
02/26
POLAR, NCT04372953 / ACTRN12618001686291: Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The Trial).

Recruiting
N/A
906
Europe, US, RoW
Positive End-Expiratory Pressure (PEEP)
Murdoch Childrens Research Institute, University of Pennsylvania, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Oxford
Lung Injury, Preterm Birth
11/26
05/28
Meena, Nikhil K
NCT05354141: Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Recruiting
3
970
US
ExoFlo, Intravenous normal saline
Direct Biologics, LLC
Acute Respiratory Distress Syndrome, ARDS
03/25
08/25
IMPALA-2, NCT04544293 / 2020-001263-85: Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

Active, not recruiting
3
160
Europe, Canada, Japan, US, RoW
Molgramostim, Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), Placebo
Savara Inc., Savara ApS,
Autoimmune Pulmonary Alveolar Proteinosis
11/23
11/24
Chowdhary, Vikas
NCT03978000 / 2018-000754-22: IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Active, not recruiting
3
2158
Europe, US, RoW
IBP-9414, Placebo
Infant Bacterial Therapeutics
Necrotizing Enterocolitis
06/24
07/24

Download Options